Last reviewed · How we verify
NCT05756478: Pro-M
Appropriate Prescribing for Older Adults With Multimorbidity (Pro-M)
NA trial testing Medication review in Potentially Inappropriate Medications in 36 participants. Completed in 16 October 2023.
16 October 2023
Quick facts
| Lead sponsor | Geriatric Education and Research Institute |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | health services research |
| Enrollment | 36 |
| Start date | 1 February 2023 |
| Primary completion | 16 October 2023 |
| Estimated completion | 16 October 2023 |
| Sites | 2 locations across Singapore |
Drugs / interventions tested
- Medication review
Conditions studied
- Potentially Inappropriate Medications — all drugs for Potentially Inappropriate Medications →
- Multimorbidity — all drugs for Multimorbidity →
- Polypharmacy — all drugs for Polypharmacy →
Sponsor
Geriatric Education and Research Institute
Who can join
Adults 21 to 99, any sex, with Potentially Inappropriate Medications or Multimorbidity. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a two-site feasibility study to test implementation of an intervention that aims to reduce inappropriate prescribing for older adults with multimorbidity in geriatric medicine specialist clinics at public hospitals in Singapore. The specific aims are: 1. To assess the implementation outcomes: Appropriateness, Penetration/Reach, Acceptability, Feasibility, Sustainability (primary) 2. To collect data on recruitment and pre-post data on prevalence of potentially inappropriate prescribing (PIP) for the purpose of determining sample size for a scale up next phase study (secondary). 3. To conduct cost analysis of the intervention (secondary).
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Appropriate Prescribing for older adults with Multimorbidity (Pro-M): protocol for a feasibility study.
Tang JY, Teng PHJ, Chen CY, Tan KT, et al · · 2024 · PMID 38500190 · DOI 10.1186/s13690-024-01264-x
Verify or expand the search:
- PubMed search for NCT05756478
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Medication review
Trials testing the same drug.
- NCT07283055 — A Swiss Interprofessional Network for Reviewing Inappropriate Medication in Primary Care · NA · enrolling by invitation
- NCT05928104 — Optimising Pharmacist-led Medication Reviews in Primary Care · completed
- NCT05297461 — Impact of Medication Review by Community Pharmacists · NA · completed
- NCT04573491 — Implementation of Pharmacogenetic Testing in Hospital Wards · NA · completed
- NCT05390736 — Evaluating the Cost Effectiveness of STEADI · NA · completed
Other recruiting trials for Potentially Inappropriate Medications
Currently open trials in the same condition.
- NCT05875623 — Impact of Medications Review on Potentially Inappropriate Medications and Clinical Outcomes Among Hospitalized Older Adu · NA · active not recruiting
- NCT05336565 — PIM Incidence in Older Cardiovascular Patients During COVID-19 Pandemics · recruiting
Other Geriatric Education and Research Institute trials
Trials by the same sponsor.
- NCT06753643 — An Intrinsic Capacity Identification and Management Programme for Older Adults in Singapore's Primary Care · not yet recruiting
- NCT04788251 — Falls Prevention Evaluation and Development for Older Adults in the Community · NA · completed
- NCT04549103 — Effect of Baduanjin on Functional Performance in Pre-Frail/Frail Older Adults · NA · completed
- NCT04866316 — Protocol for Multi-site Evaluation of New Community-based Frailty Programme · completed
- NCT04438876 — The Effects of Functional Power Training on Frail and Pre-frail Community - Dwelling Older Adults in Singapore · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05756478 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Geriatric Education and Research Institute
- Last refreshed: 9 February 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05756478.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing